Invech Holdings, Inc. cash flow statement IVHI

In fiscal 2025, which ended Dec 31, 2025, Invech Holdings, Inc. used $58,258 of cash from operations, up 5.6% from the year before.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line
FY 2026
Jun 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
Operating
Operating cash flow
-0
+46.0%
-0
+5.6%
-0
Investing
Investing cash flow
0
0
0
Financing
Financing cash flow
0
-45.9%
0
+6.4%
0
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Services-Management Consulting Services (SIC 8742)
Listed as
IVHI (OTC)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Las Vegas, NV
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1009919
Former names
Amersin Life Sciences CORP (until Aug 2, 2006); HUBEI PHARMACEUTICAL GROUP LTD (until Jan 31, 2005); PAN ASIA COMMUNICATIONS CORP (until Mar 20, 2003); EXPLORE TECHNOLOGIES INC (until Jun 25, 2002)

Other Services-Management Consulting Services companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.